| EN

Newanti®:Biapenem for injection

Newanti®:Biapenem for injection

Indications:

 Newanti® is used for the treatment of septicemia, pneumonia and lung abscess caused by sensitive bacteria, secondary infections caused by chronic respiratory disease, refractory cystitis, pyelonephritis, peritonitis and annexitis. It is primarily used to treat critically-ill, hospitalized patients suffering from serious infections, and is predominantly consumed in hospitals’ intensive care units and respiratory and hematology departments.

Biapenem has been recommended as a primary carbapenem antibiotic in a number of clinical practice guidelines, including the National Guidelines for Antimicrobial Therapy (《国家抗微生物治疗指南》) issued by NHC in 2012, the Guidelines for Clinical Application of Antibacterial Drugs (2015) (《抗菌药物临床应用指导原则2015年版》) issued by NHC, the China Adults Community-Acquired Pneumonia Diagnosis and Treatment Guidelines (2016) (《中国成人小区获得性肺炎诊断和治疗指南(2016)) and the China Adults Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia Diagnosis and Treatment Guidelines (2018) (《中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018)), and the Consensus among Experts on Diagnosis and Treatment for End-Stage Liver Disease with Infection (2018) (《终末期肝病合并感染诊治专家共识(2018)) issued by Chinese Medical Association. Moreover, biapenem has also been recommended by the Guidelines for Treatment of Respiratory Tract Infection (《呼吸道感染治疗指南》) issued by the Japanese Association for Infectious Diseases and Japanese Society of Chemotherapy in Japan in 2016.